Navigation Links
A New Anti-Cancer Drug Keeps Resistance Out

An experimental drug named Dasatinib, developed by Bristol-Myers Squibb company offers a valuable treatment against the signs and symptoms of chronic myeloid leukemia// patients than the usual drug named Gleevec.

Patients, who are resistant to Gleevec drug can now be treated with dasatinib, which seems to regulate intolerance and complications of chronic myeloid leukemic patients - studies published in NEJM finds.

In the phase I clinical trials dasatinib overcome Gleevec resistance in about 68 of 84 patients studied - study leader, HHMI investigator Charles L. Sawyers, and colleagues at UCLA's Jonsson Comprehensive Cancer Center, reported.

People in all 3 stages of the disease such as chronic phase, the accelerated phase, and blast crisis respond to the new drug quite possibly, Sawyers says.

Sawyers said, ‘Drug-related mutations are better understood by the application of experimental drug, dasatinib to subjects and even individual patient’s mutation type were easily studied by scientists at Bristol-Myers Squibb’.

‘How drug target mutation take place and whether molecular explanation of drugs has any role to play in it’ all studied by the scientists, showing improvements in structural biology studies.

Due to being as a ‘sloppier inhibitor’ meaning - does not hold its target to such tight structural constraints, dasatinib differs from the drug Gleevec.

Sawyers added dasatinib proves its value to overcome kinase resistance in managing cancer patients and also keep rooting in other fields of medicine like molecular oncology and structural biology.
'"/>




Page: 1

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. FDA Approves Anti-Cancer Cell Drug - Zevalin
3. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
4. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
5. Antidepressant Drug Found To Have Anti-Cancer Effects
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Exercise Has An Anti-Cancer Effect
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: